Skip to content
XPR – Lifestyle Demo
Author:
Rejuvenate Biomed NV
Rejuvenate Biomed Completes Recruitment in Phase 2 Trial Assessing First-in-Class Multi-Pathway Therapeutic RJx-01 in COPD-Induced Sarcopenia
June 1, 2026